Directory
>
Jyothy Pillai
Jyothy Pillai
VP Quality Assurance & Regulatory Affairs | Ocugen
United States
Jyothy Pillai
Summary
Jyothy Pillai is an accomplished leader in the pharmaceutical and biopharmaceutical industries, currently serving as the Vice President of Quality Assurance and Regulatory Affairs at Ocugen. With over 20 years of experience, she has a proven track record in regulatory sciences and drug development, demonstrating a strong ability to navigate complex regulatory landscapes across global markets. Her expertise encompasses analytical method validation, CMC regulatory submissions, and strategic regulatory planning, which have been pivotal in facilitating timely market access for critical therapies. Jyothy's diplomatic skills enable her to effectively liaise with health authorities worldwide, ensuring compliance and fostering collaborative relationships. She has consistently demonstrated a commitment to quality and excellence, earning accolades for her contributions to successful regulatory submissions and project management. Jyothy's dedication to mentoring and developing cross-functional teams highlights her belief in the power of collaboration and shared success in achieving organizational goals.
Jyothy Pillai
Work Experience
VP Quality Assurance & Regulatory Affairs at
Ocugen
April 2024 - Present
AVP, QA & RA at
Ocugen
October 2023 - April 2024
Senior Director Regulatory Affairs, CMC at
Ocugen
March 2022 - October 2023
Associate Director, Biologics, Reglatory Affairs at
Merck
May 2020 - March 2022
CMC Global Regulatory Project Manager, Biopharm Regulatory Affairs at
GSK
April 2018 - May 2020
Senior Advisor Biopharm QA at
GSK
January 2016 - January 2018
Sr. Scientist & Investigator at
GSK
January 2011 - January 2016
QC Supervisor, Biochem & Raw Materials at
GSK
April 2008 - January 2011
Senior Scientist, BioPharm CEDD / Quality Control | Scientist, BioPharm CEDD / QC Assoc. Scientist at
GSK
January 2002 - January 2008
Jyothy Pillai
Education
Dayalbagh Educational Institute, Master Of Science (Ms)
January 1993
Temple University, Master Of Science (Ms)
Frequently Asked Questions about Jyothy Pillai
What is Jyothy Pillai email address?
Jyothy Pillai's primary email address is *************@ocugen.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Jyothy Pillai work for?
Jyothy Pillai is a VP Quality Assurance & Regulatory Affairs at Ocugen, a company specializing in Commercial physical research.
Where Jyothy Pillai graduated from?
Jyothy Pillai holds a degree in Chemistry from Dayalbagh Educational Institute.
How can I directly contact Jyothy Pillai?
To contact Jyothy Pillai directly, you can use the email address *************@ocugen.com. Complete contact information is available upon registration with Muraena.
Who is Jyothy Pillai?
Jyothy Pillai is an accomplished leader in the pharmaceutical and biopharmaceutical industries, currently serving as the Vice President of Quality Assurance and Regulatory Affairs at Ocugen. With over 20 years of experience, she has a proven track record in regulatory sciences and drug development, demonstrating a strong ability to navigate complex regulatory landscapes across global markets. Her expertise encompasses analytical method validation, CMC regulatory submissions, and strategic regulatory planning, which have been pivotal in facilitating timely market access for critical therapies. Jyothy's diplomatic skills enable her to effectively liaise with health authorities worldwide, ensuring compliance and fostering collaborative relationships. She has consistently demonstrated a commitment to quality and excellence, earning accolades for her contributions to successful regulatory submissions and project management. Jyothy's dedication to mentoring and developing cross-functional teams highlights her belief in the power of collaboration and shared success in achieving organizational goals.
Jyothy`s contact details
*************@ocugen.com
Colleagues
Chairman, CEO and Co-Founder
Senior Vice President, Commercial
Chief Scientific Officer